Matches in SemOpenAlex for { <https://semopenalex.org/work/W4378173406> ?p ?o ?g. }
- W4378173406 endingPage "193229682311763" @default.
- W4378173406 startingPage "193229682311763" @default.
- W4378173406 abstract "Very few patient-reported outcomes have been published in regard to opinions of individuals with type 1 diabetes concerning adjunctive therapy. The aim of this subanalysis was to qualitatively and quantitatively assess the thoughts and experiences of participants with type 1 diabetes who have used low doses of empagliflozin as an adjunct to hybrid closed-loop therapy.Semi-structured interviews were performed with adult participants who completed a double-blinded, crossover, randomized controlled trial using low-dose empagliflozin as an adjunct to hybrid closed-loop therapy. Participant experiences were captured through qualitative and quantitative methods. A descriptive analysis was performed using a qualitative approach; attitudes toward relevant topics were extracted from interview transcripts.Twenty-four participants were interviewed; 15 (63%) perceived differences between interventions despite blinding, due to glycemic control or side effects. Advantages that arose were better glycemic control, in particular postprandially, requiring less insulin, and ease of use. Disadvantages were thought to be adverse effects, increased incidence of hypoglycemia, and increased pill burden. Thirteen (54%) participants were interested in using low-dose empagliflozin beyond the study.Many participants had positive experiences with low-dose empagliflozin as an adjunct to the hybrid closed-loop therapy. A dedicated study with unblinding would be beneficial to better characterize patient-reported outcomes." @default.
- W4378173406 created "2023-05-26" @default.
- W4378173406 creator A5014668215 @default.
- W4378173406 creator A5020314374 @default.
- W4378173406 creator A5047498706 @default.
- W4378173406 creator A5077247868 @default.
- W4378173406 date "2023-05-25" @default.
- W4378173406 modified "2023-09-25" @default.
- W4378173406 title "Participant Experiences of Low-Dose Empagliflozin Use as Adjunct Therapy to Hybrid Closed Loop: Findings From a Randomized Controlled Trial" @default.
- W4378173406 cites W1968938093 @default.
- W4378173406 cites W2051135812 @default.
- W4378173406 cites W2123384152 @default.
- W4378173406 cites W2146264128 @default.
- W4378173406 cites W2331113014 @default.
- W4378173406 cites W2494601841 @default.
- W4378173406 cites W2514658869 @default.
- W4378173406 cites W2599850051 @default.
- W4378173406 cites W2604712698 @default.
- W4378173406 cites W2617858914 @default.
- W4378173406 cites W2626446274 @default.
- W4378173406 cites W2728705426 @default.
- W4378173406 cites W2779316037 @default.
- W4378173406 cites W2799357239 @default.
- W4378173406 cites W2909166675 @default.
- W4378173406 cites W2913123058 @default.
- W4378173406 cites W2935716280 @default.
- W4378173406 cites W2945423314 @default.
- W4378173406 cites W2981310284 @default.
- W4378173406 cites W3001789911 @default.
- W4378173406 cites W3006574853 @default.
- W4378173406 cites W3017287973 @default.
- W4378173406 cites W3042558568 @default.
- W4378173406 cites W3044223210 @default.
- W4378173406 cites W3046019290 @default.
- W4378173406 cites W3081830235 @default.
- W4378173406 cites W3088173406 @default.
- W4378173406 cites W3088399797 @default.
- W4378173406 cites W3089612515 @default.
- W4378173406 cites W3104260886 @default.
- W4378173406 cites W3118986275 @default.
- W4378173406 cites W3127371223 @default.
- W4378173406 cites W3127792526 @default.
- W4378173406 cites W3128903399 @default.
- W4378173406 cites W3149039834 @default.
- W4378173406 cites W3166779635 @default.
- W4378173406 cites W4221122205 @default.
- W4378173406 cites W4280580357 @default.
- W4378173406 cites W4308188102 @default.
- W4378173406 cites W807162506 @default.
- W4378173406 doi "https://doi.org/10.1177/19322968231176302" @default.
- W4378173406 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37226831" @default.
- W4378173406 hasPublicationYear "2023" @default.
- W4378173406 type Work @default.
- W4378173406 citedByCount "0" @default.
- W4378173406 crossrefType "journal-article" @default.
- W4378173406 hasAuthorship W4378173406A5014668215 @default.
- W4378173406 hasAuthorship W4378173406A5020314374 @default.
- W4378173406 hasAuthorship W4378173406A5047498706 @default.
- W4378173406 hasAuthorship W4378173406A5077247868 @default.
- W4378173406 hasConcept C126322002 @default.
- W4378173406 hasConcept C134018914 @default.
- W4378173406 hasConcept C138885662 @default.
- W4378173406 hasConcept C141071460 @default.
- W4378173406 hasConcept C168563851 @default.
- W4378173406 hasConcept C197934379 @default.
- W4378173406 hasConcept C2771230 @default.
- W4378173406 hasConcept C2775887513 @default.
- W4378173406 hasConcept C2777056012 @default.
- W4378173406 hasConcept C2777180221 @default.
- W4378173406 hasConcept C2779306644 @default.
- W4378173406 hasConcept C2780473172 @default.
- W4378173406 hasConcept C2780668416 @default.
- W4378173406 hasConcept C41895202 @default.
- W4378173406 hasConcept C555293320 @default.
- W4378173406 hasConcept C71924100 @default.
- W4378173406 hasConceptScore W4378173406C126322002 @default.
- W4378173406 hasConceptScore W4378173406C134018914 @default.
- W4378173406 hasConceptScore W4378173406C138885662 @default.
- W4378173406 hasConceptScore W4378173406C141071460 @default.
- W4378173406 hasConceptScore W4378173406C168563851 @default.
- W4378173406 hasConceptScore W4378173406C197934379 @default.
- W4378173406 hasConceptScore W4378173406C2771230 @default.
- W4378173406 hasConceptScore W4378173406C2775887513 @default.
- W4378173406 hasConceptScore W4378173406C2777056012 @default.
- W4378173406 hasConceptScore W4378173406C2777180221 @default.
- W4378173406 hasConceptScore W4378173406C2779306644 @default.
- W4378173406 hasConceptScore W4378173406C2780473172 @default.
- W4378173406 hasConceptScore W4378173406C2780668416 @default.
- W4378173406 hasConceptScore W4378173406C41895202 @default.
- W4378173406 hasConceptScore W4378173406C555293320 @default.
- W4378173406 hasConceptScore W4378173406C71924100 @default.
- W4378173406 hasFunder F4320306080 @default.
- W4378173406 hasLocation W43781734061 @default.
- W4378173406 hasLocation W43781734062 @default.
- W4378173406 hasOpenAccess W4378173406 @default.
- W4378173406 hasPrimaryLocation W43781734061 @default.
- W4378173406 hasRelatedWork W2045745834 @default.
- W4378173406 hasRelatedWork W2248252442 @default.